Trivariate's Adam Parker Outlines 10-Year AI Spending Cycle, Bullish Case for Memory Chips and Healthcare
Summarized by AI from reporting by Phil Rosen, published under our editorial policy.
Trivariate Research founder Adam Parker believes the market is only a third of the way through an eight-to-twelve-year AI capital expenditure cycle. Speaking on the AI trade's trajectory, Parker highlighted strong fundamentals in memory semiconductors and healthcare while advising against traditional buy-and-hold strategies.
In a recent discussion on the trajectory of artificial intelligence investments, Trivariate Research founder Adam Parker outlined a bullish multi-year outlook for the sector, arguing that the market is only about one-third of the way through an eight-to-twelve-year capital spending cycle that began in May 2023. Addressing concerns over capital availability and debt financing among hyperscalers, Parker emphasized that core cash flows remain robust enough to fund continued expansion. He singled out memory semiconductors as a premier opportunity, dismissing traditional cyclical bear arguments against companies like Micron Technology. Pointing to persistent shortages in compute and power, Parker argued that memory suppliers are positioned for unprecedented cash generation over the coming quarters.
Rethinking Portfolio Construction
Parker also highlighted structural shifts in portfolio management, suggesting that traditional ten-year buy-and-hold approaches and heavily concentrated portfolios have become less effective since 2019. According to Trivariate's empirical research, market dynamics driven by passive strategies, multi-strategy funds, and options trading have made concentrated stock selection more volatile. Furthermore, data shows that mean-reverting tactics—such as adding capital to losing positions—have delivered their worst relative performance in 25 years. Instead, stocks experiencing upward price momentum and rising valuation multiples into earnings prints have demonstrated a significantly higher probability of beating analyst expectations.
Sector Allocations and Long-Term Outlook
Beyond power infrastructure and semiconductors, Parker urged investors to overweight the healthcare sector for both growth and risk management. He identified precision diagnostics, medical technology, and drug distribution as high-growth areas, noting that labor-heavy healthcare companies will also become major productivity beneficiaries of AI tools between 2027 and 2029. Conversely, he expressed caution toward IT services, financials, and consumer staples. Looking toward the late 2020s and 2030s, Parker anticipated a broader industrial revolution in the U.S. driven by physical AI and humanoid robotics, which he expects will sustain silicon demand for years to come.